Absci Corporation (ABSI)

US — Healthcare Sector
Peers: RXRX  AFMD  SANA  RLAY  EXAI  VECT  ZURA  ELEV  ICVX  AVRO  HEPA  DTIL  CRBU  CFRX  GRPH  DAWN  ABOS  XFOR  INZY 

Automate Your Wheel Strategy on ABSI

With Tiblio's Option Bot, you can configure your own wheel strategy including ABSI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ABSI
  • Rev/Share 0.0292
  • Book/Share 1.5972
  • PB 1.7781
  • Debt/Equity 0.0414
  • CurrentRatio 5.7175
  • ROIC -0.413

 

  • MktCap 362267560.0
  • FreeCF/Share -0.6171
  • PFCF -4.7166
  • PE -3.2888
  • Debt/Assets 0.0354
  • DivYield 0
  • ROE -0.5369

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 3
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation ABSI Needham -- Buy -- $9 Jan. 22, 2025
Initiation ABSI Guggenheim -- Buy -- $10 Oct. 2, 2024

News

Absci to Participate in Upcoming Investor Conferences
ABSI
Published: March 26, 2025 by: GlobeNewsWire
Sentiment: Neutral

VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences.

Read More
image for news Absci to Participate in Upcoming Investor Conferences
Absci to Participate in the TD Cowen 45th Annual Health Care Conference
ABSI
Published: February 18, 2025 by: GlobeNewsWire
Sentiment: Neutral

VANCOUVER, Wash. and NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming TD Cowen 45th Annual Health Care Conference in Boston, MA.

Read More
image for news Absci to Participate in the TD Cowen 45th Annual Health Care Conference

About Absci Corporation (ABSI)

  • IPO Date 2021-07-22
  • Website https://www.absci.com
  • Industry Biotechnology
  • CEO Mr. Sean McClain
  • Employees 156

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.